CYP19A1 and breast cancer: The aim of this study was to explore whether the expression level of the aromatase protein in carcinoma cells alone or in combination with PR expression in the primary tumor may be predictive for response to treatment with the AI letrozole or the AE tamoxifen in the advanced breast cancer setting.